Sort by
Refine Your Search
-
The National Industry PhD Program is an Australian Government initiative to enhance workforce mobility among graduate researchers, and to promote knowledge transfer between academia and industries
-
modelling, enabling more cost-efficient training algorithms. Program overview The successful candidate will receive: Admission to a PhD program at the University of Adelaide; A four-year scholarship package
-
. The organisation is currently working on research project(s) related to the release of a new digital product that conducts optimisation of AI algorithms for sustainable home retrofitting solutions. Opportunity
-
learning. This program allows students to conduct cutting-edge AI research at a world-class institute and provides travel funding to gain valuable experience working with international collaborators in
-
and polyploid crop species and benchmark them against other methods such as graph-based methods. This project will combine algorithm development and computational programming with large population
-
research travel is essential for the pursuit of the research project, this may include travel to the partner university to undertake a joint PhD program, invitations to continue aspects of their research
-
-driven research in cancer bioinformatics, leveraging cutting-edge techniques to unravel complex biological insights. Join us in advancing cancer research through innovative computational approaches. As a
-
need: A PhD in Molecular Biology, Cell Biology, Genetics, Biotechnology, or a related area. Expertise and interest in cancer and/or stem cell biology and associated techniques. Outstanding academic track
-
-performance computing (HPC), Bragg Crystallography facility, and Adelaide Proteomics Centre. Our collaboration with Monash University further extends our access to advanced 300 kV Titan Krios and Helios 5 UX
-
identified. For further information For a confidential discussion regarding this position, contact: Dr Luke Isbel Group Leader in the Cancer Epigenetics Program at the South Australian immunoGENomics Cancer